Philip Poortmans unpaid guest prof.

Publications Philip Poortmans

EUROPA trial : cost implications of radiotherapy versus endocrine therapy

Source
The lancet oncology - ISSN 1470-2045-26:4 (2025) p. e183-e183
Author(s)

The impact of loco-regional treatment on ipsilateral breast cancer recurrence and outcomes in carriers of BRCA1/2 pathogenic variants

Source
Breast cancer research and treatment - ISSN 0167-6806- (2025) p.
Author(s)
    Rinat Bernstein-Molho, Ory Haisraely, Shira Galper, Narmeen Abu-Shhada, Einav Nili Gal-Yam, Tehillah S. Menes, Philip Poortmans, Orit Kaidar-Person

Adapting radiation therapy to immunotherapy : delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial

Source
Radiotherapy and oncology - ISSN 0167-8140-206 (2025) p. 1-10
Author(s)
    A. De Caluwe, S. Bellal, K. Cao, K. Peignaux, V. Remouchamps, A. Baten, E. Longton, I. Bessieres, J. Vu-Bezin, Y. Kirova, D. Van Gestel, I. Desmoulins, M. Ignatiadis, E. Romano, L. Buisseret, M. Piccart, C. Vandekerkhove, A. Gulyban, Philip Poortmans

Tumour-infiltrating lymphocytes and radiation therapy in rectal cancer : systematic review and meta-analysis

Source
Clinical oncology - ISSN 0936-6555-39 (2025) p. 1-17
Author(s)

The 2024 Assisi think tank on breast cancer : focus on the use of a tumour bed boost after breast conserving therapy

Source
The Breast - ISSN 0960-9776-80 (2025) p. 1-8
Author(s)
    Meritxell Arenas, Yasemin Boluekbasi, Liesbeth J. Boersma, Birgitte Offersen, Vassilis Kouloulias, Isabella Palumbo, Lurdes Trigo, Laura Lozza, Fabio Marazzi, Marco Trovo, Sofia Rivera, Orit Kaidar-Person, Charlotte Coles, Icro Meattini, Vincenzo Valentini, Cynthia Aristei, Philip Poortmans